| Date Filed | Type | Description |
| 06/30/2023 |
4
| Smith Hunter C (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 1,950,000 options to buy
@ $0.3, valued at
$585k
|
|
| 02/14/2023 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 702 shares
@ $26.87, valued at
$18.9k
Exercised 2,344 restricted stock units
@ $0 |
|
| 02/14/2023 |
4/A
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 1,413 shares
@ $27.51, valued at
$38.9k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 833 shares
@ $6.1, valued at
$5.1k
Exercised 2,344 restricted stock units
@ $0 |
|
| 02/11/2022 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 16,250 restricted stock units
@ $0
Granted 97,500 options to buy
@ $6.8, valued at
$663k
|
|
| 11/16/2021 |
4
| Smith Hunter C (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $7.04, valued at
$422.4k
|
|
| 11/16/2021 |
3
| Smith Hunter C (Director) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 04/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,375 restricted stock units
@ $0
Granted 56,250 options to buy
@ $30.66, valued at
$1.7M
|
|
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 25,000 options to buy
@ $22.53, valued at
$563.3k
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2020 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Exercised 3,500 options to buy
@ $6.88, valued at
$24.1k
|
|
| 02/19/2020 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 82,000 options to buy
@ $17.87, valued at
$1.5M
|
|
| 01/29/2020 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Exercised 6,250 options to buy
@ $6.88, valued at
$43k
|
|
| 12/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2019 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Exercised 10,000 options to buy
@ $6.88, valued at
$68.8k
|
|
| 07/02/2019 |
4
| Smith Hunter C (Director) has filed a Form 4 on GENESEE & WYOMING INC|
Txns:
| Granted 307 shares
@ $98.57, valued at
$30.3k
|
|
| 05/24/2019 |
4
| Smith Hunter C (Director) has filed a Form 4 on GENESEE & WYOMING INC|
Txns:
| Granted 1,161 shares
@ $86.07, valued at
$99.9k
|
|
| 04/02/2019 |
4
| Smith Hunter C (Director) has filed a Form 4 on GENESEE & WYOMING INC|
Txns:
| Granted 291 shares
@ $86.88, valued at
$25.3k
|
|
| 02/15/2019 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 70,000 options to buy
@ $29.78, valued at
$2.1M
|
|
| 02/04/2019 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Exercised 3,000 options to buy
@ $6.88, valued at
$20.6k
|
|
| 01/03/2019 |
4
| Smith Hunter C (Director) has filed a Form 4 on GENESEE & WYOMING INC|
Txns:
| Granted 326 shares
@ $73.8, valued at
$24.1k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2018 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Exercised 3,000 options to buy
@ $6.88, valued at
$20.6k
|
|
| 07/03/2018 |
4
| Smith Hunter C (Director) has filed a Form 4 on GENESEE & WYOMING INC|
Txns:
| Granted 229 shares
@ $80.48, valued at
$18.4k
|
|
| 05/25/2018 |
4
| Smith Hunter C (Director) has filed a Form 4 on GENESEE & WYOMING INC|
Txns:
| Granted 1,301 shares
@ $0 |
|
|